October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
October 03, 2019
I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular ...
October 02, 2019
September 27, 2019 — Ancora Heart Inc. announced results from an interim analysis of heart failure patients treated in ...
September 27, 2019Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept. 30 ...
September 20, 2019
September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
September 18, 2019
September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...
September 12, 2019
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...
September 11, 2019
September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 11, 2019
September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...
September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...
September 09, 2019
September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...
September 09, 2019
September 4, 2019 – Novartis announced results from two new clinical trials evaluating improvement in heart structure ...
September 04, 2019
August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of ...
August 22, 2019
August 19, 2019 — People suffering from insomnia may have an increased risk of coronary artery disease, heart failure an ...
August 19, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now